Quantinno Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Quantinno Capital Management's VKTX Position: Q3 2026 in Review
Quantinno Capital Management increased its Viking Therapeutics (VKTX) stake by 129% in Q3 2026, buying an estimated $2.65M and bringing the position to 135,393 shares worth $4.41M. The position accounts for ﹤0.01% of the portfolio, ranked #1542.
Quantinno Capital Management first reported a position in VKTX in Q2 2025 and has held it in 6 quarters since. 443 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Quantinno Capital Management held 135,393 shares of Viking Therapeutics worth $4.41M as of Q3 2026.
- Quantinno Capital Management bought 76,385 Viking Therapeutics shares in Q3 2026, an estimated $2.65M.
- Viking Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1542 holding.
- Quantinno Capital Management first reported a position in Viking Therapeutics in Q2 2025 and has held it in 6 quarters since.
- 443 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.